Insights

Commercial Expansion NEXGEL is transitioning from hospital wound care to Consumer OTC, Rx, Medical Device and Cosmetic applications, presenting sales opportunities across multiple high-volume channels and product adjacencies.

Strategic Partnerships Recent alignment with Sequence Life Science and integration of BioNX Surgical assets signal an openness to collaborate on manufacturing, distribution, and financing, creating potential co-sell and channel partnership opportunities.

Leadership Transitions Board and executive changes, including interim CEO appointment and governance shifts, indicate a period of strategic realignment ideal for engaging C-suite and corporate development prospects to influence partnerships and investment discussions.

Financial Signals Q2 revenue of 3.69 million with GAAP net loss and a disclosed funding of 27 million suggests growth investments and urgency for scalable commercial models, enabling sales pitches around accelerated commercialization and cost-efficient production.

Operational Readiness Acquired assets and manufacturing transition work point to readiness for scaled production and new product launches; sales teams can target medical devices, cosmetics, and wound care customers seeking reliable supply, regulatory alignment, and rapid time-to-market.

Similar companies to NEXGEL Advanced Hydrogel Solutions

NEXGEL Advanced Hydrogel Solutions Tech Stack

NEXGEL Advanced Hydrogel Solutions uses 8 technology products and services including Sucuri, WordPress, Figma, and more. Explore NEXGEL Advanced Hydrogel Solutions's tech stack below.

Media & News

NEXGEL Advanced Hydrogel Solutions's Email Address Formats

NEXGEL Advanced Hydrogel Solutions uses at least 1 email format:
NEXGEL Advanced Hydrogel Solutions Email FormatsExamplePercentage
FLast@nexgel.comJDoe@nexgel.com
100%

Frequently Asked Questions

What is NEXGEL Advanced Hydrogel Solutions's official website and social media links?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions's official website is nexgel.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does NEXGEL Advanced Hydrogel Solutions generate?

Minus sign iconPlus sign icon
As of September 2026, NEXGEL Advanced Hydrogel Solutions's annual revenue is estimated to be $1M - $10M.

What is NEXGEL Advanced Hydrogel Solutions's NAICS code?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does NEXGEL Advanced Hydrogel Solutions have currently?

Minus sign iconPlus sign icon
As of September 2026, NEXGEL Advanced Hydrogel Solutions has approximately 12 employees across 1 continents, including North America. Key team members include Vice President Operations: G. R., Operations & Supply Chain Manager: A. K. and Production Supervisor: J. C. Explore NEXGEL Advanced Hydrogel Solutions's employee directory with LeadIQ.

What industry does NEXGEL Advanced Hydrogel Solutions belong to?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions operates in the Medical Equipment Manufacturing industry.

What technology does NEXGEL Advanced Hydrogel Solutions use?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions's tech stack includes Sucuri, WordPress, Figma, NetSuite, Shopify, Microsoft 365, Piwik and DigitalOcean Web Hosting.

What is NEXGEL Advanced Hydrogel Solutions's email format?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions's email format typically follows the pattern of FLast@nexgel.com. Find more NEXGEL Advanced Hydrogel Solutions email formats with LeadIQ.

How much funding has NEXGEL Advanced Hydrogel Solutions raised to date?

Minus sign iconPlus sign icon
As of September 2026, NEXGEL Advanced Hydrogel Solutions has raised $27M in funding. The last funding round occurred on Apr 21, 2026 for $950K.

When was NEXGEL Advanced Hydrogel Solutions founded?

Minus sign iconPlus sign icon
NEXGEL Advanced Hydrogel Solutions was founded in 1997.
NEXGEL Advanced Hydrogel Solutions logo

NEXGEL Advanced Hydrogel Solutions

Medical Equipment ManufacturingPennsylvania, United States11-50 Employees

NEXGEL Advanced Hydrogel Solutions is a medical equipment manufacturer based in Langhorne, Pennsylvania. It develops a trans-dermal hydrogel delivery system that was originally developed and FDA-approved for hospital wound care, and the company is expanding its use into consumer OTC, prescription, medical device, and cosmetic applications. The firm operates with a small team and focuses on bringing this delivery platform to multiple markets. In May 2026, the company appointed Dave Hazard as vice president of sales for its BIONX Surgical division to scale commercialization following a recent acquisition.

Section iconCompany Overview

Website
nexgel.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1997
Employees
11-50

Section iconFunding & Financials

  • $27M

    NEXGEL Advanced Hydrogel Solutions has raised a total of $27M of funding over 9 rounds. Their latest funding round was raised on Apr 21, 2026 in the amount of $950K as a Post IPO Debt.

  • $1M - $10M

    NEXGEL Advanced Hydrogel Solutions's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.